Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer.

BMC Cancer · 2025 · PMC11905611 · PMID 40082837

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

showed a trendp = 0.12not close (p > 0.1)

Results showed a trend of higher STMN1 expression in poor responders compared to good responders ( p = 0.12) in the ITT population (Fig. 1 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.